Interventions Risk Report
This report screens all interventions and calculates and generates forest plots of risk differences, relative risks or odds ratios.
Report Results Description
Running this report for Nicardipine using default settings generates the report shown below.
Refer to the Adverse Events Risk Report , keeping in mind the following important differences in contrast with the example:
| • | Output (including section names) reflects intervention incidence corresponding to selected domain (e.g. Concomitant Medication, Substance Use), rather than adverse events, incidence |
| • | Term Level is allowed to equal Category (such as CMCAT or SUCAT, depending on the domain) |
Refer to Confidence Intervals for information on how JMP Clinical calculates and uses confidence intervals.
Report Data Filters
These filters enable you to subset and view subjects based on demographic characteristics and other criteria. Refer to Data Filter for more information.
Note: Filter specifications are reapplied when any widget options are changed.
Options
Use the widgets on this panel to customize your analysis.
Domain
Use the Domain option to specify whether to plot the distribution of either exposure (EX) or concomitant medications (CM) events.
Term Level
Term Levels are determined by the coding dictionary for the Event domain of interest, typically these levels follow the MedDRA dictionary. Use this widget to specify how each adverse event is named and the level at which the event is considered. For example, selecting Reported Term reports the event specified by the actual event term as reported in either the EX or CM domains. Refer to Term Level for more information.
Intervention Type
Intervention Type
Analysis can consider all events or only those that emerge at specific times before, during, or after the trial period. For example, selecting On treatment interventions as the Intervention Type includes only those interventions that occur on or after the first dose of study drug and at or before the last dose of drug (+ the offset for end of dosing).
Ignore available treatment emergent flags
If you choose to Ignore available treatment emergent flags, the analysis includes all adverse events that occur on or after day 1 of the study.
Risk Measurement
You have the option of calculating either the Risk Difference, the Relative Risk, or the Odds Ratio as the Risk Measurement.
Display Risk Difference as:
Use this widget to specify the difference between the risk of an event in the treatment arm and the control arm as either a percentage or a proportion of the total subject population. This widget appears only when you select Risk Difference as the Risk Measurement.
Sort Risk Report plot and tables by:
Use the Sort Risk Report plot and tables by: widget to specify how the rows in the Risk Report plot and tables are to be sorted..
General and Drill Down Buttons
Action buttons, provide you with an easy way to drill down into your data. The following action buttons are generated by this report:
| • | Click  to rerun the report using default settings. |
| • | Click  to view the associated data tables. Refer to Show Tables/View Data for more information. |
| • | Click  to generate a standardized pdf- or rtf-formatted report containing the plots and charts of selected sections. |
| • | Click  to generate a JMP Live report. Refer to Create Live Report for more information. |
| • | Click  to take notes, and store them in a central location. Refer to Add Notes for more information. |
| • | Click  to read user-generated notes. Refer to View Notes for more information. |
Default Settings
Refer to Set Study Preferences for default Subject Level settings.
Methodology
Patients are assessed for each intervention they experience and Percent Occurrence and Risk Difference are calculated for each intervention by treatment group. Percent Occurrence is simply the percentage of patients in a treatment group who experience the intervention at least once during the trial period. Risk difference is calculated by subtracting the number of patients exhibiting the intervention in the control group from the number of patients exhibiting the intervention in the treatment arm